CSPC Pharmaceutical Group Investor Relations Material
Latest events
Q1 2025
29 May, 2025
H2 2024
28 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CSPC Pharmaceutical Group Limited
Access all reports
CSPC Pharmaceutical Group Limited is a China-based pharmaceutical company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through multiple segments, including finished drugs, bulk drug manufacturing, and innovative drug development. Its product portfolio spans a range of therapeutic areas such as cardiovascular, oncology, anti-infectives, and central nervous system disorders. The company is headquartered in Shijiazhuang, China, and its shares are listed on the HKEX.
Key slides for CSPC Pharmaceutical Group Limited
Q1 2025
CSPC Pharmaceutical Group Limited
Q1 2025
CSPC Pharmaceutical Group Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
1093
Country
🇭🇰 Hong Kong